Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet

Annals of Medicine

Volumn 46, Issue 3, 2014, Pages 182-187

  Jonasson, Lena ^a   Guldbrand, Hans ^a   Lundberg, Anna K ^a   Nystrom, Fredrik H ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cytokine; Dietary intervention; Inflammation; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; CARBOHYDRATE; DISACCHARIDE; FAT; GLIBENCLAMIDE; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; METFORMIN; MONOSACCHARIDE; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; SUCROSE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNSATURATED FATTY ACID;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; FEMALE; FIBER; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; AGED; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS; MULTICENTER STUDY; NORMAL HUMAN;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; WEIGHT LOSS;

EID: 84899802864     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2014.894286     Document Type: Article

References (37)

1. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia. 2005; 48: 1038-50.
2. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin-6 and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286: 327-34.
3. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Infl ammatory cytokines and the risk to develop type 2 diabetes. Results of the prospective population-basedeuropean prospective investigation into cancer and nutrition (EPIC). Potsdam Study. Diabetes. 2003; 52: 812-17.
4. Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, et al. Pro-and anti-infl ammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA. Diabetologia. 2011; 54: 1630-8.
5. Luotola K, Pietila A, Zeller T, Moilanen L, Kahönen M, Nieminen MS, et al. Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J Intern Med. 2011; 269: 322-32.
6. Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, et al. Associations between insulin resistance and TNFalpha in plasma, skeletal muscle and adipose tissue in humans witHand without type 2 diabetes. Diabetologia. 2007; 50: 2562-71.
7. Aderka D. The potential biological and clinical signifi cance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 1996; 7: 231-40.
8. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-beta genes. Eur J Immunol. 1998; 28: 2598-602.
9. Ruotsalainen E, Salmenniemi U, Vauhkonen I, Pihlajama ki J, Punnonen K, Kainulainen S, et al. Changes in infl ammatory cytokines are related to impaired glucose tolerance in off spring of type 2 diabetic subjects. Diabetes Care. 2006; 29: 2714-20.
10. Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes. 1998; 47: 1757-62.
11. Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab. 2002; 87: 1184-8.
12. Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, et al. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia. 2006; 49: 387-93.
13. Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabak AG, Schloot NC, et al. Elevated levels of the anti-infl ammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the WhitehalLiI Study. Diabetes Care. 2009; 32: 421-3.
14. Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, et al. A prospective study of soluble tumor necrosis factor-a receptor II (sTNFRII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care. 2005; 28: 1376-82.
15. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012; 23: 507-15.
16. Kolb H, Manrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade infl ammation. Diabetologia. 2010; 53: 10-20.
17. Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009; 44: 297-309.
18. Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, et al. Weight and metabolic outcomes aft er 2 years on a low-carbohydrate versus low-fat diet. Ann Intern Med. 2010; 153: 147-57.
19. Salas-Salvado J, Bullo M, Babio N, Martinez-Gonzalez M A, Ibarrola-Jurado N, Basora J, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011; 34: 14-19.
20. Guldbrand H, Dizdar B, Bunjaku B, Lindström T, Bachrach- Lindström M, Fredrikson M, et al. In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia. 2012; 55: 2118-27.
21. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Eng J Med. 2013; 368: 1279-90.
22. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular infl ammation in the metabolic syndrome: a randomized trial. JAMA. 2004; 292: 1440-6.
23. Jiu S, Manson JA, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitive C-reactive protein in middle-aged women. Am J Clin Nutr. 2002; 75: 492-8.
24. Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, et al. Dietary pattern, infl ammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005; 82: 675-84.
25. Oliveira MC, Menezes-Garcia Z, Henriques MC, Soriani FM, Pinho V, Faria AM, et al. Acute and sustained infl ammation and metabolic dysfunction induced by high refi ned carbohydrate-containing diet in mice. Obesity. 2013; 21: E396-406.
26. Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of infl ammation. Lipids. 2008; 43: 65-77.
27. Davis NJ, Crandall JP, Gajavelli S, Berman JW, Tomuta N, Wylie-Rosett J, et al. Diff erential Effects of low-carbohydrate and low-fat diets on infl ammation andendothelial function in diabetes. J Diabetes Complications. 2011; 25: 371-6.
28. Leite JO, DeOgburn R, Ratliff J, Su R, Smyth JA, Volek JS, et al. Low-carbohydrate diets reduce lipid accumulation and arteriaLinfl ammation in guinea pigs fed a high-cholesterol diet. Atherosclerosis. 2010; 209; 442-8.
29. Kasim-Karakas SE, Tsodikov A, Singh U, JialaLi. Responses to infl ammatory markers to a low-fat, high-carbohydrate diet: Effects of energy intake. Am J Clin Nutr. 2006; 83: 774-9.
30. Mena MP, Sacanella E, Vazquez-Agell M, Morales M, Fito M, Escoda R, et al. Inhibition of circulating immune cell activation: a molecular antiinfl ammatory Effect of the Mediterranean diet. Am J Clin Nutr. 2009; 89: 248-56.
31. Urpi-Sarda M, Casas R, Chiva-Blanch G, Romero-Mamani ES, Valderas-Martinez P, Salas-Salvado J, et al. The Mediterranean diet pattern and its main components are associated with lower plasma concentrations of tumor necrosis factor receptor 60 in patients at high risk for cardiovascular disease. J Nutr. 2012; 142: 1019-25.
32. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Infl ammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106: 2067-72.
33. Gonzalez F, Miium J, Rote N S, Kirwan J P. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia. Metabolism. 2006; 55: 271-6.
34. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, et al. Dietary composition and nonalcoholic fatty liver disease . Dig Dis Sci. 2004; 49: 1578-83.
35. Devaraj S, Rogers J, JialaLi. Statins and biomarkers of infl ammation. Curr Atheroscler Rep. 2007; 9: 33-41.
36. Ajala O, English P, Pinkney J. Systematic review and meta-analysis of diff erent dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013; 97: 505-16.
37. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mater-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013; 37(Suppl 1): S120-43.